Ken Aitken – Managing Director – Metgasco (ASX:MEL) is a petroleum (oil and gas) exploration and production company, listed on the Australian Securities Exchange.
Copyright 2023 – Finance News Network
Source: Finance News Network
01 Oct 2024 - Hazer Group Limited (ASX:HZR) CEO Glenn Corrie provides an update on the company, discussing IP protection and moving into commercialisation.
Read More19 Jun 2024 - Patrick Bell, CEO and Director of Finexia Financial Group (ASX:FNX) speaks to Garry Crole, CEO and Managing Director of Sequoia Financial Group (ASX:SEQ). Topics discussed include the company's Childcare Income Fund and its lending business.
Read More11 Aug 2020 - Regeneus (ASX:RGS) CEO, Leo Lee talks about its collaboration with Kyocera of Japan to market Progenza its cell therapy treatment for anti-inflammatory treatment and repair of damaged or diseased tissue.
Read More03 Mar 2020 - Catapult Limited (ASX:CAT) CEO, Will Lopes discusses 1H20 results and outlook.
Read More11 Apr 2023 - Altech Batteries Limited (ASX:ATC) CFO Martin Stein discusses the company's GridPack batteries for the renewable energy storage market and progress with the CERENERGY project.
Read More03 Jun 2021 - Shaw and Partners Chief Investment Officer Martin Crabb discusses measures of growth, inflationary pressures, and similarities between post-war environments and the current economic situation.
Read More18 Oct 2019 - Calima Energy Limited (ASX:CE1) Managing Director, Alan Stein, talks about the company's strategy, recent capital raising, and results from the drill program at its Montney project.
Read More17 Nov 2023 - Findi Limited (ASX:FND) Chairman Nicholas Smedley discusses the details that its Indian subsidiary TSI has successfully raised $37.6m via a placement to leading Investment group, Piramal Alternatives.
Read More21 Aug 2020 - DigitalX Limited (ASX:DCC) Executive Director Leigh Travers provides an update on the company's strategy, its focus on blockchain consulting and development for the enterprise market and digital asset management, the impact of COVID-19, and priorities.
Read More09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler provides an update on the company's lead compound ATH434 for Multiple System Atrophy, its dual strategy in Europe and the US and its Phase 2 plans.
Read More
